Semenogelin-2 activators constitute a specialized category of chemical compounds recognized for their ability to modulate the activity of semenogelin-2, a protein predominantly found in human seminal fluid. Semenogelin-2 belongs to a family of proteins known as seminal plasma proteins and plays a critical role in the process of semen coagulation, a natural phenomenon that occurs upon ejaculation. These activators are meticulously designed to interact with semenogelin-2, influencing its functions related to coagulation, which is an essential step in sperm protection and subsequent fertility processes. At the molecular level, the mechanisms underlying semenogelin-2 activation can involve binding to specific regions of the protein, potentially affecting its conformation and interactions with other molecules involved in the coagulation process.
The study of semenogelin-2 activators is vital for understanding the intricacies of reproduction and seminal fluid biology. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact semenogelin-2's function and their downstream effects on semen coagulation. This knowledge contributes to our broader understanding of male reproductive physiology and the molecular events that facilitate sperm protection and motility within the female reproductive tract. Furthermore, these compounds serve as valuable tools for scientists seeking to investigate the molecular basis of semen coagulation and its significance in fertility, ultimately deepening our understanding of the complex processes underlying human reproduction in various scientific contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dihydrotestosterone Tridecanoate | 488836-66-4 | sc-505161 | 250 mg | $380.00 | ||
Potent androgen; could directly modulate SEMG2 expression. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $47.00 $156.00 $171.00 $525.00 $941.00 | 4 | |
Androgen receptor antagonist; might indirectly decrease SEMG2 expression. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
Inhibitor of 5-alpha reductase, enzyme converting testosterone to DHT; potential reduction in SEMG2 expression. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
Another 5-alpha reductase inhibitor; might decrease SEMG2 expression by reducing DHT levels. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Major estrogen; while primarily a female hormone, it might have indirect effects on SEMG2 expression in males. | ||||||
Clomiphene Citrate | 50-41-9 | sc-205636 sc-205636A | 1 g 5 g | $84.00 $176.00 | 1 | |
Selective estrogen receptor modulator; could indirectly influence SEMG2 via its effects on gonadotropin release. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Another selective estrogen receptor modulator; might have indirect effects on SEMG2 expression. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
While a primary female hormone, it might have indirect effects on SEMG2 expression in males. | ||||||